PremiumPre-EarningsLYEL Earnings this Week: How Will it Perform? Pacira appoints Teehan as CCO, Corbett as CBO Lyell Immunopharma price target lowered to 60c from $1 at BofA PremiumThe FlyBuy/Sell: Wall Street’s top 10 stock calls this week Lyell Immunopharma’s Strategic Moves and Leadership Expansion Lyell Immunopharma double downgraded to Underperform at BofA after reorg PremiumThe FlyLyell Immunopharma reports Q2 revenue $40.3M vs.$47M last year Dynatrace initiated, U.S. Bancorp downgraded: Wall Street’s top analyst calls Lyell Immunopharma price target lowered to $6 from $9 at BofA 
